Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Coultreon Biopharma

Clinicaltrial registered3 Nov 2026

Coultreon Biopharma

3 Nov 2026: Trial registered · A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
3 Nov 2026
Title
A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis
Conditions
Plaque Psoriasis
Phase
Phase 2
Study Type
Interventional
Status
Not Yet Recruiting
Countries
Canada
Country
Canada
Reference
NCT07914231
Location
Canada
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Coultreon Biopharma

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Canada

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.